AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...

The new tool, available as a phone app, helps identify comorbidities and produces a score to guide clinicians.

Fundamental changes in asthma management are all geared to breaking the inhalers-antibiotics-inhalers-steroids cycle ...

Each patient using inhalers with propellants in 2023 produced 140kg of CO2 emissions over a year. Read more at ...

Discover how glucocorticoid-mediated eosinopoiesis in asthma creates a paradox, influencing relapse, steroid resistance, and ...

Chiesi USA's asthma inhaler could simplify treatment for millions of Americans. Triangle Forward: What's Next for Life Sciences?

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: AstraZeneca’s recent clinical study, officially titled ...

For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.

"RN here. I don't love my career anymore. I've worked in various fields and have seen insurance companies deny life-saving ...

Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...

Patients with chronic rhinosinusitis with nasal polyps and uncontrolled asthma experienced greater improvements in lung ...